title: Getting better value from the NHS drug budget.
authors.affiliation: The Heart Hospital, London W1G 8PH, UK. james.moon@uclh.nhs.uk
authors.forename: James C
authors.initials: JC
authors.lastname: Moon
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Flett
authors.forename: Brian B
authors.initials: BB
authors.lastname: Godman
authors.forename: Anthony M
authors.initials: AM
authors.lastname: Grosso
authors.forename: Anthony S
authors.initials: AS
authors.lastname: Wierzbicki
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000191:economics*; D002017:Budgets; D016568:Drugs, Generic / Q000191:economics*; D018166:Health Care Reform; D006333:Heart Failure / Q000188:drug therapy / Q000191:economics; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000191:economics*; D006973:Hypertension / Q000188:drug therapy / Q000191:economics; D019808:Losartan / Q000191:economics*; D010330:Patents as Topic; D010818:Practice Patterns, Physicians'; D055553:Prescription Drugs / Q000191:economics; D019821:Simvastatin / Q000191:economics*; D013222:State Medicine / Q000191:economics*; D006113:United Kingdom
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D016568:Drugs, Generic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D055553:Prescription Drugs; D019821:Simvastatin; D019808:Losartan